[HTML][HTML] COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …

[HTML][HTML] Should children be vaccinated against COVID-19?

P Zimmermann, LF Pittet, A Finn, AJ Pollard… - Archives of disease in …, 2022 - adc.bmj.com
Whether all children under 12 years of age should be vaccinated against COVID-19 remains
an ongoing debate. The relatively low risk posed by acute COVID-19 in children, and …

2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …

Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination

DT Truong, A Dionne, JC Muniz, KE McHugh… - Circulation, 2022 - Am Heart Assoc
Background: Understanding the clinical course and short-term outcomes of suspected
myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public …

Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series

A Fazlollahi, M Zahmatyar, M Noori… - Reviews in medical …, 2022 - Wiley Online Library
There have been several local and systemic adverse events associated with mRNA COVID‐
19 vaccines. Pericarditis, myocarditis and myocardial infarction are examples of cardiac …

[HTML][HTML] Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs

S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …

Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

I Kracalik, ME Oster, KR Broder, MM Cortese… - The Lancet Child & …, 2022 - thelancet.com
Background Data on medium-term outcomes in indivduals with myocarditis after mRNA
COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life …

Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung

S Vygen-Bonnet, J Koch, C Bogdan, T Harder… - 2021 - edoc.rki.de
Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …

SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: a scientific statement from the American Heart …

PN Jone, A John, ME Oster, K Allen, AH Tremoulet… - Circulation, 2022 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) resulted in a global pandemic and has overwhelmed
health care systems worldwide. In this scientific statement, we describe the epidemiology …

[HTML][HTML] Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination

K Goddard, N Lewis, B Fireman, E Weintraub… - Vaccine, 2022 - Elsevier
Background Evidence indicates that mRNA COVID-19 vaccination is associated with risk of
myocarditis and possibly pericarditis, especially in young males. It is not clear if risk differs …